A Phase 3, Multicenter, Randomized, Double-Masked, Parallel-Group, Comparative Study to Evaluate the Clinical Efficacy and Safety of ISV-305 (0.1% Dexamethasone) Compared to Vehicle in the Treatment of Subjects With Blepharitis

Trial Profile

A Phase 3, Multicenter, Randomized, Double-Masked, Parallel-Group, Comparative Study to Evaluate the Clinical Efficacy and Safety of ISV-305 (0.1% Dexamethasone) Compared to Vehicle in the Treatment of Subjects With Blepharitis

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 19 Dec 2017

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Blepharitis
  • Focus Registrational; Therapeutic Use
  • Acronyms ISV-305
  • Sponsors InSite Vision
  • Most Recent Events

    • 13 Dec 2017 Planned primary completion date changed from 1 Aug 2018 to 1 Apr 2019.
    • 13 Dec 2017 Planned End Date changed from 1 Oct 2018 to 1 Aug 2019.
    • 13 Dec 2017 Planned initiation date changed from 1 Sep 2017 to 1 Feb 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top